Prognostic significance of CD44 molecule in renal cell carcinoma

Croatian Medical Journal

Volumn 45, Issue 6, 2004, Pages 703-708

  Lučin, Ksenija ^a   Matušan, Koviljka ^a   Dordević, Gordana ^a   Stipić, Darko ^a  

^a UNIVERSITY OF RIJEKA   (Croatia)

Author keywords

Adenocarcinoma; Carcinoma; CD44S antigen; CD44v5 antigen; CD44v6 antigen; Cell adhesion; Immunohistochemistry; Prognosis; Renal cell

Indexed keywords

HERMES ANTIGEN; KI 67 ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; CELL ADHESION; DIAGNOSTIC VALUE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; PROGNOSIS;

ANTIGENS, CD44; CARCINOMA, RENAL CELL; CROATIA; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY NEOPLASMS; MALE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 11144232342     PISSN: 03539504     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Fleming S, O'Donnell M. Surgical pathology of renal epithelial neoplasms: recent advances and current status. Histopathology. 2000;36:195-202.
2. Fuhrman SA, Lasky LC, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol. 1982;6:655-63.
3. Delahunt B. Histopathologic prognostic indicators for renal cell carcinoma. Semin Diagn Pathol. 1998;15: 68-76.
4. Juliano RL. Membrane receptors for extracellular matrix macromolecules: relationship to cell adhesion and tumor metastasis. Biochim Biophys Acta. 1987;907: 261-78.
5. Rudzki Z, Jothy S. CD44 and the adhesion of neoplastic cells. Mol Pathol. 1997;50:57-71.
6. Gunthert U, Hofmann M, Rudy W, Reber S, Zoller M, Haussmann I, et al. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell. 1991;65:13-24.
7. Joensuu H, Klemi PJ, Toikkanen S, Jalkanen S. Glycoprotein CD44 expression and its association with survival in breast cancer. Am J Pathol. 1993;143:867-74.
8. Friedrichs K, Kugler G, Franke F, Terpe HJ, Arlt J, Regidor PA, et al. CD44 isoforms in prognosis of breast cancer. Lancet. 1995;345:1237.
9. Kaufmann M, Heider KH, Sinn HP, von Minckwitz G, Ponta H, Herrlich P. CD44 variant exon epitopes in primary breast cancer and length of survival. Lancet. 1995;345:615-9.
10. Lipponen P, Aaltoma S, Kosma VM, Ala-Opas M, Eskelinen M. Expression of CD44 standard and variant-v6 proteins in transitional cell bladder tumours and their relation to prognosis during a long-term follow-up. J Pathol. 1998;186:157-64.
11. Kovacs G, Akhtar M, Beckwith BJ, Bugert P, Cooper CS, Delahunt B, et al. The Heidelberg classification of renal cell tumours. J Pathol. 1997;183:131-3.
12. Sobin LH, Wittekind CH, editors. 5th ed TNM classification of malignant tumors. New York (NY): Wiley-Liss; 2002.
13. Florquin S, Rouschop KM. Reciprocal functions of hepatocyte growth factor and transforming growth factor-beta1 in the progression of renal diseases: a role for CD44? Kidney Int Suppl. 2003;(86):S15-20.
14. Asselman M, Verhulst A, De Broe ME, Verkoelen CF. Calcium oxalate crystal adherence to hyaluronan-, osteopontin-, and CD44-expressing injured/regenerating tubular epithelial cells in rat kidneys. J Am Soc Nephrol. 2003;14:3155-66.
15. Gilcrease MZ, Guzman-Paz M, Niehans G, Cherwitz D, McCarthy JB, Albores-Saavedra J. Correlation of CD44S expression in renal clear cell carcinomas with subsequent tumor progression or recurrence. Cancer. 1999;86:2320-6.
16. Terpe HJ, Storkel S, Zimmer U, Anquez V, Fischer C, Pantel K, et al. Expression of CD44 isoforms in renal cell tumors. Positive correlation to tumor differentiation. Am J Pathol. 1996;148:453-63.
17. Paradis V, Ferlicot S, Ghannam E, Zeimoura L, Blanchet P, Eschwege P, et al. CD44 is an independent prognostic factor in conventional renal cell carcinomas. J Urol. 1999;161:1984-7.
18. Daniel L, Lechevallier E, Giorgi R, Lindner V, De Fromont M, Vieillefond A, et al. CD44s and CD44v6 expression in localized T1-T2 conventional renal cell carcinomas. J Pathol. 2001;193:345-9.
19. Gilcrease MZ, Truong L, Brown RW. Correlation of very late activation integrin and CD44 expression with extrarenal invasion and metastasis of renal cell carcinomas. Hum Pathol. 1996;27:1355-60.
20. Hara I, Miyake H, Yamanaka K, Hara S, Arakawa S, Kamidono S. Expression of CD44 adhesion molecules in nonpapillary renal cell carcinoma and normal kidneys. Urology. 1999;54:562-6.
21. Rioux-Leclercq N, Epstein JI, Bansard JY, Turlin B, Patard JJ, Manunta A, et al. Clinical significance of cell proliferation, microvessel density, and CD44 adhesion molecule expression in renal cell carcinoma. Hum Pathol. 2001;32:1209-15.
22. Alho AM, Underhill CB. The hyaluronate receptor is preferentially expressed on proliferating epithelial cells. J Cell Biol. 1989;108:1557-65.
23. Wobus M, Rangwala R, Sheyn I, Hennigan R, Coila B, Lower EE, et al. CD44 associates with EGFR and erbB2 in metastasizing mammary carcinoma cells. Appl Immunohistochem Mol Morphol. 2002;10:34-9.
24. Moch H, Sauter G, Buchholz N, Gasser TC, Bubendorf L, Waldman FM, et al. Epidermal growth factor receptor expression is associated with rapid tumor cell proliferation in renal cell carcinoma. Hum Pathol. 1997;28: 1255-9.
25. Heider KH, Hofmann M, Hors E, van den Berg F, Ponta H, Herrlich P, et al. A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps. J Cell Biol. 1993;120:227-33.
26. Miller RT, Estran C. Heat-induced epitope retrieval with a pressure cooker: suggestions for optimal use. Appl Immunohistochem. 1995;3:190-3.
27. Turley EA, Noble PW, Bourguignon LY. Signaling properties of hyaluronan receptors. J Biol Chem. 2002;277: 4589-92.
28. Yu Q, Stamenkovic I. Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion. Genes Dev. 1999;13: 35-48.
29. Bennett KL, Jackson DG, Simon JC, Tanczos E, Peach R, Modrell B, et al. CD44 isoforms containing exon V3 are responsible for the presentation of heparin-binding growth factor. J Cell Biol. 1995;128:687-98.
30. Griffioen AW, Coenen MJ, Damen CA, Hellwig SM, van Weering DH, Vooys W, et al. CD44 is involved in tumor angiogenesis; an activation antigen on human endothelial cells. Blood. 1997;90:1150-9.